[1]

Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, et al. 1987. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50:509−517

doi: 10.1016/0092-8674(87)90504-6
[2]

Özsarlak Ö, Schepens E, Parizel PM, Van Goethem JW, Vanhoenacker F, et al. 2001. Hereditary neuromuscular diseases. European Journal of Radiology 40:184−197

doi: 10.1016/S0720-048X(01)00399-0
[3]

Flanigan KM. 2014. Duchenne and Becker muscular dystrophies. Neurologic Clinics 32:671−688

doi: 10.1016/j.ncl.2014.05.002
[4]

Orso M, Migliore A, Polistena B, Russo E, Gatto F, et al. 2023. Duchenne muscular dystrophy in Italy: a systematic review of epidemiology, quality of life, treatment adherence, and economic impact. PLoS One 18:e0287774

doi: 10.1371/journal.pone.0287774
[5]

Rudolfsen JH, Vissing J, Werlauff U, Olesen C, Illum N, et al. 2024. Burden of disease of Duchenne muscular dystrophy in Denmark – a national register-based study of individuals with duchenne muscular dystrophy and their closest relatives. Journal of Neuromuscular Diseases 11:443−457

doi: 10.3233/JND-230133
[6]

Crisafulli S, Sultana J, Fontana A, Salvo F, Messina S, et al. 2020. Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis. Orphanet Journal of Rare Diseases 15:141

doi: 10.1186/s13023-020-01430-8
[7]

Monaco AP, Bertelson CJ, Liechti-Gallati S, Moser H, Kunkel LM. 1988. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 2:90−95

doi: 10.1016/0888-7543(88)90113-9
[8]

Waite A, Tinsley CL, Locke M, Blake DJ. 2009. The neurobiology of the dystrophin-associated glycoprotein complex. Annals of Medicine 41:344−359

doi: 10.1080/07853890802668522
[9]

Catapano F, Alkharji R, Chambers D, Singh S, Aghaeipour A, et al. 2025. A comprehensive spatiotemporal map of dystrophin isoform expression in the developing and adult human brain. Acta Neuropathologica Communications 13:110

doi: 10.1186/s40478-025-01996-z
[10]

Aartsma-Rus A, Van Deutekom JCT, Fokkema IF, Van Ommen GJ, Den Dunnen JT. 2006. Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule. Muscle & Nerve 34:135−144

doi: 10.1002/mus.20586
[11]

Pearce JMS. 2005. Early observations on Duchenne-Meryon muscular dystrophy. European Neurology 54:46−48

doi: 10.1159/000087386
[12]

Whitehead NP, Yeung EW, Allen DG. 2006. Muscle damage in mdx (dystrophic) mice: role of calcium and reactive oxygen species. Clinical and Experimental Pharmacology & Physiology 33:657−662

doi: 10.1111/j.1440-1681.2006.04394.x
[13]

Duan D, Goemans N, Takeda S, Mercuri E, Aartsma-Rus A. 2021. Duchenne muscular dystrophy. Nature Reviews Disease Primers 7:13

doi: 10.1038/s41572-021-00248-3
[14]

Dowling JJ, Weihl CC, Spencer MJ. 2021. Molecular and cellular basis of genetically inherited skeletal muscle disorders. Nature Reviews Molecular Cell Biology 22:713−732

doi: 10.1038/s41580-021-00389-z
[15]

Nico B, Paola Nicchia G, Frigeri A, Corsi P, Mangieri D, et al. 2004. Altered blood-brain barrier development in dystrophic MDX mice. Neuroscience 125:921−935

doi: 10.1016/j.neuroscience.2004.02.008
[16]

Pratt SJP, Shah SB, Ward CW, Kerr JP, Stains JP, et al. 2015. Recovery of altered neuromuscular junction morphology and muscle function in mdx mice after injury. Cellular and Molecular Life Sciences 72:153−164

doi: 10.1007/s00018-014-1663-7
[17]

Banks GB, Chamberlain JS, Froehner SC. 2009. Truncated dystrophins can influence neuromuscular synapse structure. Molecular and Cellular Neurosciences 40:433−441

doi: 10.1016/j.mcn.2008.12.011
[18]

Imaizumi R, Yamamoto T, Masui K, Ishigaki K, Sato T, et al. 2024. Spinal cord findings in a long-term survivor of Duchenne muscular dystrophy. Human Pathology Reports 37:300759

doi: 10.1016/j.hpr.2024.300759
[19]

Zarrouki F, Goutal S, Vacca O, Garcia L, Tournier N, et al. 2022. Abnormal expression of synaptic and extrasynaptic GABAA receptor subunits in the dystrophin-deficient mdx mouse. International Journal of Molecular Sciences 23:12617

doi: 10.3390/ijms232012617
[20]

Simões GF, de Oliveira AL. 2012. Granulocyte-colony stimulating factor improves MDX mouse response to peripheral nerve injury. PLoS One 7:e42803

doi: 10.1371/journal.pone.0042803
[21]

Grady RM, Wozniak DF, Ohlemiller KK, Sanes JR. 2006. Cerebellar synaptic defects and abnormal motor behavior in mice lacking α- and β-dystrobrevin. The Journal of Neuroscience 26:2841−2851

doi: 10.1523/JNEUROSCI.4823-05.2006
[22]

Mao Q, Ahmadi A, van Doorne L, de Vries S, Heezen L, et al. 2024. Evaluating genetic therapies targeting the central nervous system in Duchenne muscular dystrophy using high-resolution spatial transcriptomics. Neuromuscular Disorders 43:104441.501

doi: 10.1016/j.nmd.2024.07.510
[23]

Prigogine C, Ruiz JM, Cebolla AM, Deconinck N, Servais L, et al. 2024. Cerebellar dysfunction in the mdx mouse model of Duchenne muscular dystrophy: an electrophysiological and behavioural study. The European Journal of Neuroscience 60:6470−6489

doi: 10.1111/ejn.16566
[24]

Kueh SLL, Dempster J, Head SI, Morley JW. 2011. Reduced postsynaptic GABAA receptor number and enhanced gaboxadol induced change in holding currents in Purkinje cells of the dystrophin-deficient mdx mouse. Neurobiology of Disease 43:558−564

doi: 10.1016/j.nbd.2011.05.002
[25]

Knuesel I, Mastrocola M, Zuellig RA, Bornhauser B, Schaub MC, et al. 1999. Altered synaptic clustering of GABAA receptors in mice lacking dystrophin (mdx mice). The European Journal of Neuroscience 11:4457−4462

doi: 10.1046/j.1460-9568.1999.00887.x
[26]

Brünig I, Suter A, Knuesel I, Lüscher B, Fritschy JM. 2002. GABAergic terminals are required for postsynaptic clustering of dystrophin but not of GABAA receptors and gephyrin. Journal of Neuroscience 22:4805−4813

doi: 10.1523/JNEUROSCI.22-12-04805.2002
[27]

Fuenzalida M, Espinoza C, Pérez MÁ, Tapia-Rojas C, Cuitino L, et al. 2016. Wnt signaling pathway improves central inhibitory synaptic transmission in a mouse model of Duchenne muscular dystrophy. Neurobiology of Disease 86:109−120

doi: 10.1016/j.nbd.2015.11.018
[28]

Sekiguchi M, Zushida K, Yoshida M, Maekawa M, Kamichi S, et al. 2009. A deficit of brain dystrophin impairs specific amygdala GABAergic transmission and enhances defensive behaviour in mice. Brain 132:124−135

doi: 10.1093/brain/awn253
[29]

Kahle KT, Staley KJ, Nahed BV, Gamba G, Hebert SC, et al. 2008. Roles of the cation-chloride cotransporters in neurological disease. Nature Clinical Practice Neurology 4:490−503

doi: 10.1038/ncpneuro0883
[30]

Pressey JC, Mahadevan V, Woodin MA. 2020. KCC2 is a hub protein that balances excitation and inhibition. Neuronal Chloride Transporters in Health and Disease, ed. Tang X. US: Academic Press. pp. 159–179 doi: 10.1016/B978-0-12-815318-5.00008-X
[31]

Jarvis R, Ng SFJ, Nathanson AJ, Cardarelli RA, Abiraman K, et al. 2023. Direct activation of KCC2 arrests benzodiazepine refractory status epilepticus and limits the subsequent neuronal injury in mice. Cell Reports Medicine 4:100957

doi: 10.1016/j.xcrm.2023.100957
[32]

Pressey JC, de Saint-Rome M, Raveendran VA, Woodin MA. 2023. Chloride transporters controlling neuronal excitability. Physiological Reviews 103:1095−1135

doi: 10.1152/physrev.00025.2021
[33]

Hartmann AM, Nothwang HG. 2022. NKCC1 and KCC2: structural insights into phospho-regulation. Frontiers in Molecular Neuroscience 15:964488

doi: 10.3389/fnmol.2022.964488
[34]

Coe BP, Girirajan S, Eichler EE. 2012. The genetic variability and commonality of neurodevelopmental disease. American Journal of Medical Genetics Part C, Seminars in Medical Genetics 160C:118−129

doi: 10.1002/ajmg.c.31327
[35]

Cross AL, Viswanath O, Sherman AL. 2026. Pregabalin. In StatPearls. Treasure Island (FL): StatPearls Publishing
[36]

Reznikov LR. 2017. Cystic fibrosis and the nervous system. Chest 151:1147−1155

doi: 10.1016/j.chest.2016.11.009
[37]

Mulberg AE, Wiedner EB, Bao X, Marshall J, Jefferson DM, et al. 1994. Cystic fibrosis transmembrane conductance regulator protein expression in brain. NeuroReport 5:1684

doi: 10.1097/00001756-199408150-00035
[38]

Coull JAM, Boudreau D, Bachand K, Prescott SA, Nault F, et al. 2003. Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain. Nature 424:938−942

doi: 10.1038/nature01868
[39]

De Luca A, Pierno S, Camerino C, Huxtable RJ, Camerino DC. 1998. Effect of taurine on excitation-contraction coupling of extensor digitorum longus muscle of dystrophic MDX mouse. In Taurine 3, eds Schaffer S, Lombardini JB, Huxtable RJ. Vol. 442. Boston, MA: Springer. pp. 115–119 doi: 10.1007/978-1-4899-0117-0_15
[40]

Pato CN, Davis MH, Doughty MJ, Bryant SH, Gruenstein E. 1983. Increased membrane permeability to chloride in Duchenne muscular dystrophy fibroblasts and its relationship to muscle function. Proceedings of the National Academy of Sciences of the United States of America 80:4732−4736

doi: 10.1073/pnas.80.15.4732
[41]

Kreis R, Wingeier K, Vermathen P, Giger E, Joncourt F, et al. 2011. Brain metabolite composition in relation to cognitive function and dystrophin mutations in boys with Duchenne muscular dystrophy. NMR in Biomedicine 24:253−262

doi: 10.1002/nbm.1582
[42]

Hübner CA, Stein V, Hermans-Borgmeyer I, Meyer T, Ballanyi K, et al. 2001. Disruption of KCC2 reveals an essential role of K-Cl cotransport already in early synaptic inhibition. Neuron 30:515−524

doi: 10.1016/S0896-6273(01)00297-5
[43]

Coull JAM, Beggs S, Boudreau D, Boivin D, Tsuda M, et al. 2005. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 438:1017−1021

doi: 10.1038/nature04223
[44]

Gagnon M, Bergeron MJ, Lavertu G, Castonguay A, Tripathy S, et al. 2013. Chloride extrusion enhancers as novel therapeutics for neurological diseases. Nature Medicine 19:1524−1528

doi: 10.1038/nm.3356
[45]

Doyon N, Vinay L, Prescott SA, De Koninck Y. 2016. Chloride regulation: a dynamic equilibrium crucial for synaptic inhibition. Neuron 89:1157−1172

doi: 10.1016/j.neuron.2016.02.030
[46]

Rivera C, Voipio J, Payne JA, Ruusuvuori E, Lahtinen H, et al. 1999. The K+/Cl− co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation. Nature 397:251−255

doi: 10.1038/16697
[47]

Markkanen M, Uvarov P, Airaksinen MS. 2008. Role of upstream stimulating factors in the transcriptional regulation of the neuron-specific K-Cl cotransporter KCC2. Brain Research 1236:8−15

doi: 10.1016/j.brainres.2008.08.007
[48]

Uvarov P, Pruunsild P, Timmusk T, Airaksinen MS. 2005. Neuronal K+/Cl− co-transporter (KCC2) transgenes lacking neurone restrictive silencer element recapitulate CNS neurone-specific expression and developmental up-regulation of endogenous KCC2 gene. Journal of Neurochemistry 95:1144−1155

doi: 10.1111/j.1471-4159.2005.03434.x
[49]

Karadsheh MF, Delpire E. 2001. Neuronal restrictive silencing element is found in the KCC2 gene: molecular basis for KCC2-specific expression in neurons. Journal of Neurophysiology 85:995−997

doi: 10.1152/jn.2001.85.2.995
[50]

Cai J, Wu Z, Wang G, Zhao X, Wang X, et al. 2024. The suppressive effect of the specific KCC2 modulator CLP290 on seizure in mice. Epilepsy Research 203:107365

doi: 10.1016/j.eplepsyres.2024.107365
[51]

Mizobuti DS, Fogaça AR, Moraes FDSR, Moraes LHR, Mâncio RD, et al. 2019. Coenzyme Q10 supplementation acts as antioxidant on dystrophic muscle cells. Cell Stress & Chaperones 24:1175−1185

doi: 10.1007/s12192-019-01039-2
[52]

Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72:248−254

doi: 10.1016/0003-2697(76)90527-3
[53]

Mendes LF, Gaspar VM, Conde TA, Mano JF, Duarte IF. 2019. Flavonoid-mediated immunomodulation of human macrophages involves key metabolites and metabolic pathways. Scientific Reports 9:14906

doi: 10.1038/s41598-019-51113-z
[54]

Nogueira-Ferreira R, Santos I, Ferreira R, Fontoura D, Sousa-Mendes C, et al. 2023. Exercise training impacts skeletal muscle remodelling induced by metabolic syndrome in ZSF1 rats through metabolism regulation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1869:166709

doi: 10.1016/j.bbadis.2023.166709
[55]

Sander H, Wallace S, Plouse R, Tiwari S, Gomes AV. 2019. Ponceau S waste: Ponceau S staining for total protein normalization. Analytical Biochemistry 575:44−53

doi: 10.1016/j.ab.2019.03.010
[56]

Helbing DL, Böhm L, Oraha N, Stabenow LK, Cui Y. 2022. A Ponceau S staining-based dot blot assay for rapid protein quantification of biological samples. Gels 8:43

doi: 10.3390/gels8010043
[57]

Bear MF, Connors BW, Paradiso MA. 2020. Neuroscience: exploring the brain, Enhanced edition. Burlington: Jones & Bartlett Learning. 975 pp
[58]

Wu D, Hersh LB. 1994. Choline acetyltransferase: celebrating its fiftieth year. Journal of Neurochemistry 62:1653−1663

doi: 10.1046/j.1471-4159.1994.62051653.x
[59]

Yin X, Li J, Shin HD, Du G, Liu L, et al. 2015. Metabolic engineering in the biotechnological production of organic acids in the tricarboxylic acid cycle of microorganisms: advances and prospects. Biotechnology Advances 33:830−841

doi: 10.1016/j.biotechadv.2015.04.006
[60]

Sato HH, Kawaguti HY. 2016. Biotechnological production of organic acids. In Biotechnological Production of Natural Ingredients for Food Industry. U.A.E.: Bentham Science Publishers. pp. 164–206 doi: 10.2174/9781681082653116010007
[61]

Bhakoo KK, Craig T, Pearce D. 2006. N-acetylaspartate metabolism in neural cells. In N-Acetylaspartate: A Unique Neuronal Molecule in the Central Nervous System, eds Moffett JR, Tieman SB, Weinberger DR, Coyle JT, Namboodiri AMA. Boston, MA: Springer. pp. 27–47 doi: 10.1007/0-387-30172-0_3
[62]

Coyle JT. 2006. A brief overview of N-acetylaspartate and N-acetylaspartylglutamate. In N-Acetylaspartate: A Unique Neuronal Molecule in the Central Nervous System, eds Moffett JR, Tieman SB, Weinberger DR, Coyle JT, Namboodiri AMA. vol 576. Boston, MA: Springer. pp. 1–6 doi: 10.1007/0-387-30172-0_1
[63]

Bezerra JCB, Kemper A, Becker W. 1999. Profile of organic acid concentrations in the digestive gland and hemolymph of Biomphalaria glabrata under estivation. Memórias do Instituto Oswaldo Cruz 94:779−784

doi: 10.1590/S0074-02761999000600012
[64]

Brosnan JT, Brosnan ME. 2013. Glutamate: a truly functional amino acid. Amino Acids 45:413−418

doi: 10.1007/s00726-012-1280-4
[65]

Holeček M. 2023. Roles of malate and aspartate in gluconeogenesis in various physiological and pathological states. Metabolism 145:155614

doi: 10.1016/j.metabol.2023.155614
[66]

Kusukawa T, Niwa G, Sasaki T, Oosawa R, Himeno W, et al. 2013. Observation of a hydrogen-bonded 3D structure of crystalline glycerol. Bulletin of the Chemical Society of Japan 86:351−353

doi: 10.1246/bcsj.20120300
[67]

Croze ML, Soulage CO. 2013. Potential role and therapeutic interests of myo-inositol in metabolic diseases. Biochimie 95:1811−1827

doi: 10.1016/j.biochi.2013.05.011
[68]

Kanehisa M, Goto S. 2000. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Research 28:27−30

doi: 10.1093/nar/28.1.27
[69]

Wilson ADH, Hart A, Wiberg M, Terenghi G. 2010. Acetyl-L-carnitine increases nerve regeneration and target organ reinnervation - a morphological study. Journal of Plastic, Reconstructive & Aesthetic Surgery 63:1186−1195

doi: 10.1016/j.bjps.2009.05.039
[70]

Ory-Lavollée L, Blakely RD, Coyle JT. 1987. Neurochemical and immunocytochemical studies on the distribution of N-acetyl-aspartylglutamate and N-acetyl-aspartate in rat spinal cord and some peripheral nervous tissues. Journal of Neurochemistry 48:895−899

doi: 10.1111/j.1471-4159.1987.tb05601.x
[71]

Helvacioglu F, Kandemir E, Karabacak B, Karatas I, Pecen A, et al. 2018. Effect of creatine on rat sciatic nerve injury: a comparative ultrastructural study. Turkish Neurosurgery 28:128−136

doi: 10.5137/1019-5149.jtn.18806-16.0
[72]

Yao JK, Cannon KP. 1983. [14]C Acetate metabolism in the peripheral nervous system. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 753:331−338

doi: 10.1016/0005-2760(83)90056-5
[73]

Rich LR, Ransom BR, Brown AM. 2022. Energy metabolism in mouse sciatic nerve a fibres during increased energy demand. Metabolites 12:505

doi: 10.3390/metabo12060505
[74]

Padilla S, Freeman EB, Tandon P, Wilson VZ. 1993. Locally synthesized phosphatidylcholine, but not protein, undergoes rapid retrograde axonal transport in the rat sciatic nerve. Journal of Neurochemistry 60:1900−1905

doi: 10.1111/j.1471-4159.1993.tb13418.x
[75]

Natarajan V, Yao JK, Dyck PJ, Schmid HHO. 1982. Early stimulation of phosphatidylcholine biosynthesis during Wallerian degeneration of rat sciatic nerve. Journal of Neurochemistry 38:1419−1428

doi: 10.1111/j.1471-4159.1982.tb07921.x
[76]

Zhu X, Eichberg J. 1990. A myo-inositol pool utilized for phosphatidylinositol synthesis is depleted in sciatic nerve from rats with streptozotocin-induced diabetes. Proceedings of the National Academy of Sciences of the United States of America 87:9818−9822

doi: 10.1073/pnas.87.24.9818
[77]

Mayhew JA, Gillon KRW, Hawthorne JN. 1983. Free and lipid inositol, sorbitol and sugars in sciatic nerve obtained post-mortem from diabetic patients and control subjects. Diabetologia 24:13−15

doi: 10.1007/bf00275940
[78]

Stevens MJ, Lattimer SA, Kamijo M, Van Huysen C, Sima AAF, et al. 1993. Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat. Diabetologia 36:608−614

doi: 10.1007/BF00404069
[79]

Ino D, Iino M. 2017. Schwann cell mitochondria as key regulators in the development and maintenance of peripheral nerve axons. Cellular and Molecular Life Sciences 74:827−835

doi: 10.1007/s00018-016-2364-1
[80]

Brosnan ME, Brosnan JT. 2016. Formate: the neglected member of one-carbon metabolism. Annual Review of Nutrition 36:369−388

doi: 10.1146/annurev-nutr-071715-050738
[81]

Assis AD, Chiarotto GB, Simões GF, Oliveira ALR. 2021. Pregabalin-induced neuroprotection and gait improvement in dystrophic MDX mice. Molecular and Cellular Neuroscience 114:103632

doi: 10.1016/j.mcn.2021.103632
[82]

Assis AD, Chiarotto GB, da Silva NS, Simões GF, Oliveira ALR. 2022. Pregabalin synchronizes the regeneration of nerve and muscle fibers optimizing the gait recovery of MDX dystrophic mice. FASEB Journal 36:e22511

doi: 10.1096/fj.202200411RR
[83]

Tanabe Y, Esaki K, Nomura T. 1986. Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse. Acta Neuropathologica 69:91−95

doi: 10.1007/BF00687043
[84]

Lopez MA, Bontiff S, Adeyeye M, Shaibani AI, Alexander MS, et al. 2021. Mechanics of dystrophin deficient skeletal muscles in very young mice and effects of age. American Journal of Physiology-Cell Physiology 321:C230−C246

doi: 10.1152/ajpcell.00155.2019
[85]

De La Porte S, Morin S, Koenig J. 1999. Characteristics of skeletal muscle in mdx mutant mice. International Review of Cytology 191:99−148

doi: 10.1016/s0074-7696(08)60158-8
[86]

Ray PN, Belfall B, Duff C, Logan C, Kean V, et al. 1985. Cloning of the breakpoint of an X;21 translocation associated with Duchenne muscular dystrophy. Nature 318:672−675

doi: 10.1038/318672a0
[87]

Coulton GR, Curtin NA, Morgan JE, Partridge TA. 1988. The mdx mouse skeletal muscle myopathy: II. Contractile properties. Neuropathology and Applied Neurobiology 14:299−314

doi: 10.1111/j.1365-2990.1988.tb00890.x
[88]

Dangain J, Vrbova G. 1984. Muscle development in mdx mutant mice. Muscle & Nerve 7:700−704

doi: 10.1002/mus.880070903
[89]

McGeachie JK, Grounds MD, Partridge TA, Morgan JE. 1993. Age-related changes in replication of myogenic cells in mdx mice: quantitative autoradiographic studies. Journal of the Neurological Sciences 119:169−179

doi: 10.1016/0022-510X(93)90130-Q
[90]

Timotius IK, Roelofs RF, Richmond-Hacham B, Noldus LPJJ, von Hörsten S, et al. 2023. CatWalk XT gait parameters: a review of reported parameters in pre-clinical studies of multiple central nervous system and peripheral nervous system disease models. Frontiers in Behavioral Neuroscience 17:1147784

doi: 10.3389/fnbeh.2023.1147784
[91]

D'Angelo MG, Berti M, Piccinini L, Romei M, Guglieri M, et al. 2009. Gait pattern in Duchenne muscular dystrophy. Gait & Posture 29:36−41

doi: 10.1016/j.gaitpost.2008.06.002
[92]

Pitzer C, Kurpiers B, Eltokhi A. 2021. Gait performance of adolescent mice assessed by the CatWalk XT depends on age, strain and sex and correlates with speed and body weight. Scientific Reports 11:21372

doi: 10.1038/s41598-021-00625-8
[93]

Garrick JM, Costa LG, Cole TB, Marsillach J. 2021. Evaluating gait and locomotion in rodents with the CatWalk. Current Protocols 1:e220

doi: 10.1002/cpz1.220
[94]

Rizzi JS, de Barros Almeida C, Requena LS, de Almeida VD, Mininel TV, et al. 2023. Characterization of walking locomotion in aged C57BL/10 mice: a comprehensive gait analysis. bioRxiv Preprint:535545

doi: 10.1101/2023.04.04.535545
[95]

Fritschy JM, Schweizer C, Brünig I, Lüscher B. 2003. Pre- and post-synaptic mechanisms regulating the clustering of type A γ-aminobutyric acid receptors (GABAA receptors). Biochemical Society Transactions 31:889−892

doi: 10.1042/bst0310889
[96]

Vaillend C, Chaussenot R. 2017. Relationships linking emotional, motor, cognitive and GABAergic dysfunctions in dystrophin-deficient mdx mice. Human Molecular Genetics 26:1041−1055

doi: 10.1093/hmg/ddx013
[97]

Yoshihara Y, Onodera H, Iinuma K, Itoyama Y. 2003. Abnormal kainic acid receptor density and reduced seizure susceptibility in dystrophin-deficient mdx mice. Neuroscience 117:391−395

doi: 10.1016/S0306-4522(02)00876-X
[98]

Lee HHC, Deeb TZ, Walker JA, Davies PA, Moss SJ. 2011. NMDA receptor activity downregulates KCC2 resulting in depolarizing GABAA receptor-mediated currents. Nature Neuroscience 14:736−743

doi: 10.1038/nn.2806
[99]

Chamma I, Heubl M, Chevy Q, Renner M, Moutkine I, et al. 2013. Activity-dependent regulation of the K/Cl transporter KCC2 membrane diffusion, clustering, and function in hippocampal neurons. The Journal of Neuroscience 33:15488−15503

doi: 10.1523/JNEUROSCI.5889-12.2013
[100]

Simões GF, Oliveira ALR. 2010. Alpha motoneurone input changes in dystrophic MDX mice after sciatic nerve transection. Neuropathology and Applied Neurobiology 36:55−70

doi: 10.1111/j.1365-2990.2009.01033.x
[101]

Blasco A, Gras S, Mòdol-Caballero G, Tarabal O, Casanovas A, et al. 2020. Motoneuron deafferentation and gliosis occur in association with neuromuscular regressive changes during ageing in mice. Journal of Cachexia, Sarcopenia and Muscle 11:1628−1660

doi: 10.1002/jcsm.12599
[102]

Dowling P, Zweyer M, Sabir H, Henry M, Meleady P, et al. 2023. Mass spectrometry-based proteomic characterization of the middle-aged mouse brain for animal model research of neuromuscular diseases. European Journal of Translational Myology 33:11553

doi: 10.4081/ejtm.2023.11553
[103]

Zhao P, Ignacio S, Beattie EC, Abood ME. 2008. Altered presymptomatic AMPA and cannabinoid receptor trafficking in motor neurons of ALS model mice: implications for excitotoxicity. The European Journal of Neuroscience 27:572−579

doi: 10.1111/j.1460-9568.2008.06041.x
[104]

Rivera-Cervantes MC, Torres JS, Feria-Velasco A, Armendariz-Borunda J, Beas-Zárate C. 2004. NMDA and AMPA receptor expression and cortical neuronal death are associated with p38 in glutamate-induced excitotoxicity in vivo. Journal of Neuroscience Research 76:678−687

doi: 10.1002/jnr.20103
[105]

Satarker S, Bojja SL, Gurram PC, Mudgal J, Arora D, et al. 2022. Astrocytic glutamatergic transmission and its implications in neurodegenerative disorders. Cells 11:1139

doi: 10.3390/cells11071139
[106]

Gulyás AI, Sík A, Payne JA, Kaila K, Freund TF. 2001. The KCl cotransporter, KCC2, is highly expressed in the vicinity of excitatory synapses in the rat hippocampus. The European Journal of Neuroscience 13:2205−2217

doi: 10.1046/j.0953-816x.2001.01600.x
[107]

Renner M, Schweizer C, Bannai H, Triller A, Lévi S. 2012. Diffusion barriers constrain receptors at synapses. PLoS One 7:e43032

doi: 10.1371/journal.pone.0043032
[108]

Oda Y, Imai S, Nakanishi I, Ichikawa T, Deguchi T. 1995. Immunohistochemical study on choline acetyltransferase in the spinal cord of patients with amyotrophic lateral sclerosis. Pathology International 45:933−939

doi: 10.1111/j.1440-1827.1995.tb03418.x
[109]

Fu R, Tang Y, Ling ZM, Li YQ, Cheng X, et al. 2014. Lithium enhances survival and regrowth of spinal motoneurons after ventral root avulsion. BMC Neuroscience 15:84

doi: 10.1186/1471-2202-15-84
[110]

Peddie CJ, Keast JR. 2011. Pelvic nerve injury causes a rapid decrease in expression of choline acetyltransferase and upregulation of c-Jun and ATF-3 in a distinct population of sacral preganglionic neurons. Frontiers in Neuroscience 5:6

doi: 10.3389/fnins.2011.00006
[111]

Gulino R, Vicario N, Giunta MAS, Spoto G, Calabrese G, et al. 2019. Neuromuscular plasticity in a mouse neurotoxic model of spinal motoneuronal loss. International Journal of Molecular Sciences 20:1500

doi: 10.3390/ijms20061500
[112]

Bakhit C, Armanini M, Wong WLT, Bennett GL, Wrathall JR. 1991. Increase in nerve growth factor-like immunoreactivity and decrease in choline acetyltransferase following contusive spinal cord injury. Brain Research 554:264−271

doi: 10.1016/0006-8993(91)90199-6
[113]

Laughlin SB, Sejnowski TJ. 2003. Communication in neuronal networks. Science 301:1870−1874

doi: 10.1126/science.1089662
[114]

Buzsáki G, Kaila K, Raichle M. 2007. Inhibition and brain work. Neuron 56:771−783

doi: 10.1016/j.neuron.2007.11.008
[115]

Schlattner U, Wallimann T. 2004. Metabolite channeling: creatine kinase microcompartments. In Encyclopedia of Biological Chemistry, eds Lennarz WJ, Lane MD. Amsterdam: Elsevier. pp. 646–651 doi: 10.1016/B0-12-443710-9/00642-6
[116]

Leverve XM, Taleux N, Favier R, Batandier C, Detaille D, et al. 2007. Cellular energy metabolism and integrated oxidative phosphorylation. In Molecular System Bioenergetics, ed. Weinheim SV. US: Wiley. pp. 9–27 doi: 10.1002/9783527621095.ch1
[117]

Vink R, Knoblach SM, Faden AI. 1987. 31P magnetic resonance spectroscopy of traumatic spinal cord injury. Magnetic Resonance in Medicine 5:390−394

doi: 10.1002/mrm.1910050413
[118]

Wyss PO, Huber E, Curt A, Kollias S, Freund P, et al. 2019. MR spectroscopy of the cervical spinal cord in chronic spinal cord injury. Radiology 291:131−138

doi: 10.1148/radiol.2018181037
[119]

Inoue K, Yamada J, Ueno S, Fukuda A. 2006. Brain-type creatine kinase activates neuron-specific K+-Cl− co-transporter KCC2. Journal of Neurochemistry 96:598−608

doi: 10.1111/j.1471-4159.2005.03560.x
[120]

de Los Heros P, Alessi DR, Gourlay R, Campbell DG, Deak M, et al. 2014. The WNK-regulated SPAK/OSR1 kinases directly phosphorylate and inhibit the K+-Cl−-co-transporters. The Biochemical Journal 458:559−573

doi: 10.1042/BJ20131478
[121]

Tracey I, Dunn JF, Radda GK. 1996. Brain metabolism is abnormal in the mdx model of Duchenne muscular dystrophy. Brain 119:1039−1044

doi: 10.1093/brain/119.3.1039
[122]

Rae C, Scott RB, Thompson CH, Dixon RM, Dumughn I, et al. 1998. Brain biochemistry in Duchenne muscular dystrophy: a 1H magnetic resonance and neuropsychological study. Journal of the Neurological Sciences 160:148−157

doi: 10.1016/s0022-510x(98)00190-7
[123]

Mastrostefano F, Garofalo M, Nuzzo T, Bruno C, Errico F, et al. 2025. Central neurophysiological alterations in dystrophic mdx mice correlate with reduced hippocampal levels of the endogenous NMDA receptor ligand D-aspartate. Journal of Neurochemistry 169:e70223

doi: 10.1111/jnc.70223
[124]

Pan JW, Takahashi K. 2007. Cerebral energetic effects of creatine supplementation in humans. American Journal of Physiology Regulatory, Integrative and Comparative Physiology 292:R1745−R1750

doi: 10.1152/ajpregu.00717.2006
[125]

Nelson DL, Cox MM. 2021. Lehninger principles of biochemistry, 8th ed. New York: W. H. Freeman
[126]

Moffett JR, Ross B, Arun P, Madhavarao CN, Namboodiri AMA. 2007. N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Progress in Neurobiology 81:89−131

doi: 10.1016/j.pneurobio.2006.12.003
[127]

Wallimann T, Wyss M, Brdiczka D, Nicolay K, Eppenberger HM. 1992. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. The Biochemical Journal 281:21−40

doi: 10.1042/bj2810021
[128]

Kaila K, Price TJ, Payne JA, Puskarjov M, Voipio J. 2014. Cation-chloride cotransporters in neuronal development, plasticity and disease. Nature Reviews Neuroscience 15:637−654

doi: 10.1038/nrn3819
[129]

Lapin EP, Weissbarth S, Maker HS, Lehrer GM, Weiss C. 1983. Enzyme changes in axon, myelin, and Schwann cells in injured sciatic nerve. Journal of Neuroscience Research 10:9−17

doi: 10.1002/jnr.490100103
[130]

Deck M, Van Hameren G, Campbell G, Bernard-Marissal N, Devaux J, et al. 2022. Physiology of PNS axons relies on glycolytic metabolism in myelinating Schwann cells. PLoS One 17:e0272097

doi: 10.1371/journal.pone.0272097
[131]

Bais P, Beebe K, Morelli KH, Currie ME, Norberg SN, et al. 2016. Metabolite profile of a mouse model of Charcot-Marie-Tooth type 2D neuropathy: implications for disease mechanisms and interventions. Biology Open 5:908−920

doi: 10.1242/bio.019273
[132]

Ellegood J, McKay RT, Hanstock CC, Beaulieu C. 2007. Anisotropic diffusion of metabolites in peripheral nerve using diffusion weighted magnetic resonance spectroscopy at ultra-high field. Journal of Magnetic Resonance 184:20−28

doi: 10.1016/j.jmr.2006.09.008
[133]

Wallimann T, Tokarska-Schlattner M, Schlattner U. 2011. The creatine kinase system and pleiotropic effects of creatine. Amino Acids 40:1271−1296

doi: 10.1007/s00726-011-0877-3
[134]

Antunes-Rodrigues J, De Castro M, Elias LLK, Valença MM, McCann SM. 2004. Neuroendocrine control of body fluid metabolism. Physiological Reviews 84:169−208

doi: 10.1152/physrev.00017.2003
[135]

Sparkes IA. 2010. Motoring around the plant cell: insights from plant myosins. Biochemical Society Transactions 38:833−838

doi: 10.1042/BST0380833
[136]

Jha MK, Morrison BM. 2020. Lactate transporters mediate glia-neuron metabolic crosstalk in homeostasis and disease. Frontiers in Cellular Neuroscience 14:589582

doi: 10.3389/fncel.2020.589582
[137]

Kahle KT, Khanna A, Clapham DE, Woolf CJ. 2014. Therapeutic restoration of spinal inhibition via druggable enhancement of potassium-chloride cotransporter KCC2-mediated chloride extrusion in peripheral neuropathic pain. JAMA Neurology 71:640−645

doi: 10.1001/jamaneurol.2014.21
[138]

Fünfschilling U, Supplie LM, Mahad D, Boretius S, Saab AS, et al. 2012. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 485:517−521

doi: 10.1038/nature11007
[139]

Bremer J. 1983. Carnitine—metabolism and functions. Physiological Reviews 63:1420−1480

doi: 10.1152/physrev.1983.63.4.1420
[140]

Brand A, Richter-Landsberg C, Leibfritz D. 1993. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Developmental Neuroscience 15:289−298

doi: 10.1159/000111347
[141]

Erschbamer M, Öberg J, Westman E, Sitnikov R, Olson L, et al. 2011. 1H-MRS in spinal cord injury: acute and chronic metabolite alterations in rat brain and lumbar spinal cord. The European Journal of Neuroscience 33:678−688

doi: 10.1111/j.1460-9568.2010.07562.x
[142]

Ratiney H, Sdika M, Coenradie Y, Cavassila S, van Ormondt D, et al. 2005. Time-domain semi-parametric estimation based on a metabolite basis set. NMR in Biomedicine 18:1−13

doi: 10.1002/nbm.895
[143]

Klein J. 2000. Membrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipids. Journal of Neural Transmission 107:1027−1063

doi: 10.1007/s007020070051
[144]

Podo F. 1999. Tumour phospholipid metabolism. NMR in Biomedicine 12:413−439

doi: 10.1002/(sici)1099-1492(199911)12:7413::aid-nbm587>3.3.co;2-l
[145]

Govindaraju V, Young K, Maudsley AA. 2000. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR in Biomedicine 13:129−153

doi: 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V
[146]

Maki T, Liang AC, Miyamoto N, Lo EH, Arai K. 2013. Mechanisms of oligodendrocyte regeneration from ventricular-subventricular zone-derived progenitor cells in white matter diseases. Frontiers in Cellular Neuroscience 7:275

doi: 10.3389/fncel.2013.00275
[147]

Bouçanova F, Chrast R. 2020. Metabolic interaction between Schwann cells and axons under physiological and disease conditions. Frontiers in Cellular Neuroscience 14:148

doi: 10.3389/fncel.2020.00148
[148]

Bowery NG, Smart TG. 2006. GABA and glycine as neurotransmitters: a brief history. British Journal of Pharmacology 147:S109−S119

doi: 10.1038/sj.bjp.0706443
[149]

Meldrum BS. 2000. Glutamate as a neurotransmitter in the brain: review of physiology and pathology. The Journal of Nutrition 130:1007S−1015S

doi: 10.1093/jn/130.4.1007S
[150]

El Idrissi A, Trenkner E. 2004. Taurine as a modulator of excitatory and inhibitory neurotransmission. Neurochemical Research 29:189−197

doi: 10.1023/B:NERE.0000010448.17740.6e
[151]

Cruzat V, Macedo Rogero M, Noel Keane K, Curi R, Newsholme P. 2018. Glutamine: metabolism and immune function, supplementation and clinical translation. Nutrients 10:1564

doi: 10.3390/nu10111564
[152]

McKenna MC, Waagepetersen HS, Schousboe A, Sonnewald U. 2006. Neuronal and astrocytic shuttle mechanisms for cytosolic-mitochondrial transfer of reducing equivalents: current evidence and pharmacological tools. Biochemical Pharmacology 71:399−407

doi: 10.1016/j.bcp.2005.10.011
[153]

Newsholme P, Lima MMR, Procopio J, Pithon-Curi TC, Doi SQ, et al. 2003. Glutamine and glutamate as vital metabolites. Brazilian Journal of Medical and Biological Research 36:153−163

doi: 10.1590/S0100-879X2003000200002
[154]

Kadowaki M, Kanazawa T. 2003. Amino acids as regulators of proteolysis. The Journal of Nutrition 133:2052S−2056S

doi: 10.1093/jn/133.6.2052S
[155]

Li K, Shi X, Luo M, Inam-U-Llah, Wu P, et al. 2019. Taurine protects against myelin damage of sciatic nerve in diabetic peripheral neuropathy rats by controlling apoptosis of Schwann cells via NGF/Akt/GSK3β pathway. Experimental Cell Research 383:111557

doi: 10.1016/j.yexcr.2019.111557
[156]

Wu JY, Prentice H. 2010. Role of taurine in the central nervous system. Journal of Biomedical Science 17:S1

doi: 10.1186/1423-0127-17-S1-S1
[157]

Gruener R, Bryant HJ. 1975. Excitability modulation by taurine: action on axon membrane permeabilities. The Journal of Pharmacology and Experimental Therapeutics 194:514−521

doi: 10.1016/s0022-3565(25)30286-7
[158]

Natale CA, Christie MJ, Aubrey KR. 2023. Spinal glycinergic currents are reduced in a rat model of neuropathic pain following partial nerve ligation but not chronic constriction injury. Journal of Neurophysiology 129:333−341

doi: 10.1152/jn.00451.2022
[159]

Wood RL, Calvo PM, McCallum WM, English AW, Alvarez FJ. 2024. GABA and glycine synaptic release on axotomized motoneuron cell bodies promotes motor axon regeneration. bioRxiv Preprint:623863

doi: 10.1101/2024.11.18.623863
[160]

Rojas DR, Kuner R, Agarwal N. 2019. Metabolomic signature of type 1 diabetes-induced sensory loss and nerve damage in diabetic neuropathy. Journal of Molecular Medicine 97:845−854

doi: 10.1007/s00109-019-01781-1
[161]

Zhang Q, Song W, Liang X, Xie J, Shi Y, et al. 2020. A metabolic insight into the neuroprotective effect of Jin-Mai-Tong (JMT) decoction on diabetic rats with peripheral neuropathy using untargeted metabolomics strategy. Frontiers in Pharmacology 11:221

doi: 10.3389/fphar.2020.00221
[162]

Jha MK, Lee Y, Russell KA, Yang F, Dastgheyb RM, et al. 2020. Monocarboxylate transporter 1 in Schwann cells contributes to maintenance of sensory nerve myelination during aging. Glia 68:161−177

doi: 10.1002/glia.23710
[163]

Mentch SJ, Locasale JW. 2016. One-carbon metabolism and epigenetics: understanding the specificity. Annals of the New York Academy of Sciences 1363:91−98

doi: 10.1111/nyas.12956
[164]

Moussaieff A, Rouleau M, Kitsberg D, Cohen M, Levy G, et al. 2015. Glycolysis-mediated changes in acetyl-CoA and histone acetylation control the early differentiation of embryonic stem cells. Cell Metabolism 21:392−402

doi: 10.1016/j.cmet.2015.02.002
[165]

Joseph J, Cho DS, Doles JD. 2018. Metabolomic analyses reveal extensive progenitor cell deficiencies in a mouse model of Duchenne muscular dystrophy. Metabolites 8:61

doi: 10.3390/metabo8040061
[166]

Khattri RB, Batra A, White Z, Hammers D, Ryan TE, et al. 2024. Comparative lipidomic and metabolomic profiling of mdx and severe mdx-apolipoprotein e-null mice. Skeletal Muscle 14:36

doi: 10.1186/s13395-024-00368-w
[167]

Zolkipli Z, Mai L, Lamhonwah AM, Tein I. 2012. The mdx mouse as a model for carnitine deficiency in the pathogenesis of Duchenne muscular dystrophy. Muscle & Nerve 46:767−772

doi: 10.1002/mus.23368
[168]

Johnson EE, Ervasti JM. 2025. Stress exposure in the mdx mouse model of Duchenne muscular dystrophy provokes a widespread metabolic response. The FEBS Journal 292:5067−5085

doi: 10.1111/febs.70029
[169]

Stephenson KA, Xiao Q, Vaughan MB, Peters P, Denley C, et al. 2025. Neuronal hyperexcitability in dystrophin-deficient mdx hippocampal neurons: the importance of interleukin-6 and GABAergic regulation. Scientific Reports 15:18984

doi: 10.1038/s41598-025-00880-z